An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
ORNL’s Zhenglong Li led a team tasked with improving the current technique for converting ethanol to C3+ olefins and demonstrated a unique composite catalyst that upends current practice and drives down costs. The research was published in ACS Catalysis.
At the Department of Energy’s Oak Ridge National Laboratory, scientists use artificial intelligence, or AI, to accelerate the discovery and development of materials for energy and information technologies.